Escalating polypharmacy
New drug treatments, new indications for older drug treatments, lower thresholds for treating risk factors in preventative medicine, and an ageing population acquiring multiple pathologies all contribute to the development of polypharmacy. Longitudinal studies document the rise in prescribed medicat...
Gespeichert in:
| Veröffentlicht in: | QJM : An International Journal of Medicine 2006-11, Vol.99 (11), p.797-800 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 800 |
|---|---|
| container_issue | 11 |
| container_start_page | 797 |
| container_title | QJM : An International Journal of Medicine |
| container_volume | 99 |
| creator | Gorard, D A |
| description | New drug treatments, new indications for older drug treatments, lower thresholds for treating risk factors in preventative medicine, and an ageing population acquiring multiple pathologies all contribute to the development of polypharmacy. Longitudinal studies document the rise in prescribed medications, particularly in the elderly. The potential dangers of adverse drug reactions and interactions, poor adherence and confusion associated with ever-increasing polypharmacy are likely to worsen. Strategies to reduce prescribing will obviously decrease the dangers of polypharmacy. These include more considered prescribing when contemplating additions to patients' already lengthy prescription lists, and external reviews of medicine lists by a doctor or pharmacist. Despite such strategies, polypharmacy seems inevitable and considerations must be given to simplifying patients' multiple drug administrations using single-daily-dose regimens, fixed-dose combination pills, calendar-blister packaging and pill organizers. |
| doi_str_mv | 10.1093/qjmed/hcl109 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_29853096</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1155578231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-177e611d358567cce42ff829e9c6a72951ff4ff270eeb80ba06f84e8722710833</originalsourceid><addsrcrecordid>eNqNkD1PwzAQhi0EoqWwIbEhxMBE6Nk-x_ZYVeVDqsQCs-W6Nm2VNKndDPn3pLQwsMB0d68evdI9hFxSeKCg-XCzKv18uHBFdx2RPsUcMsY1P_7eJRM9cpbSCgBQojolPSqBg2CqT64mydnCbpfrj5u6Ktp6YWNpXXtOToItkr84zAF5f5y8jZ-z6evTy3g0zRyi3GZUSp9TOudCiVw655GFoJj22uVWMi1oCBgCk-D9TMHMQh4UeiUZkxQU5wNyt--tY7VpfNqacpmcLwq79lWTDNNKcND5P0AhEenfjVRzoSmqDrz9Ba6qJq67bw1jGqVQyDrofg-5WKUUfTB1XJY2toaC2fk3X_7N3n-HXx86m9ku_oEPwvkndS1_CA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229475842</pqid></control><display><type>article</type><title>Escalating polypharmacy</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Gorard, D A</creator><creatorcontrib>Gorard, D A</creatorcontrib><description>New drug treatments, new indications for older drug treatments, lower thresholds for treating risk factors in preventative medicine, and an ageing population acquiring multiple pathologies all contribute to the development of polypharmacy. Longitudinal studies document the rise in prescribed medications, particularly in the elderly. The potential dangers of adverse drug reactions and interactions, poor adherence and confusion associated with ever-increasing polypharmacy are likely to worsen. Strategies to reduce prescribing will obviously decrease the dangers of polypharmacy. These include more considered prescribing when contemplating additions to patients' already lengthy prescription lists, and external reviews of medicine lists by a doctor or pharmacist. Despite such strategies, polypharmacy seems inevitable and considerations must be given to simplifying patients' multiple drug administrations using single-daily-dose regimens, fixed-dose combination pills, calendar-blister packaging and pill organizers.</description><identifier>ISSN: 1460-2725</identifier><identifier>EISSN: 1460-2393</identifier><identifier>DOI: 10.1093/qjmed/hcl109</identifier><identifier>PMID: 17030528</identifier><language>eng</language><publisher>England: Oxford Publishing Limited (England)</publisher><subject>Aged ; Aged, 80 and over ; Drug Interactions ; Humans ; Polypharmacy ; Self Administration</subject><ispartof>QJM : An International Journal of Medicine, 2006-11, Vol.99 (11), p.797-800</ispartof><rights>Copyright Oxford University Press(England) Nov 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-177e611d358567cce42ff829e9c6a72951ff4ff270eeb80ba06f84e8722710833</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17030528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gorard, D A</creatorcontrib><title>Escalating polypharmacy</title><title>QJM : An International Journal of Medicine</title><addtitle>QJM</addtitle><description>New drug treatments, new indications for older drug treatments, lower thresholds for treating risk factors in preventative medicine, and an ageing population acquiring multiple pathologies all contribute to the development of polypharmacy. Longitudinal studies document the rise in prescribed medications, particularly in the elderly. The potential dangers of adverse drug reactions and interactions, poor adherence and confusion associated with ever-increasing polypharmacy are likely to worsen. Strategies to reduce prescribing will obviously decrease the dangers of polypharmacy. These include more considered prescribing when contemplating additions to patients' already lengthy prescription lists, and external reviews of medicine lists by a doctor or pharmacist. Despite such strategies, polypharmacy seems inevitable and considerations must be given to simplifying patients' multiple drug administrations using single-daily-dose regimens, fixed-dose combination pills, calendar-blister packaging and pill organizers.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Drug Interactions</subject><subject>Humans</subject><subject>Polypharmacy</subject><subject>Self Administration</subject><issn>1460-2725</issn><issn>1460-2393</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkD1PwzAQhi0EoqWwIbEhxMBE6Nk-x_ZYVeVDqsQCs-W6Nm2VNKndDPn3pLQwsMB0d68evdI9hFxSeKCg-XCzKv18uHBFdx2RPsUcMsY1P_7eJRM9cpbSCgBQojolPSqBg2CqT64mydnCbpfrj5u6Ktp6YWNpXXtOToItkr84zAF5f5y8jZ-z6evTy3g0zRyi3GZUSp9TOudCiVw655GFoJj22uVWMi1oCBgCk-D9TMHMQh4UeiUZkxQU5wNyt--tY7VpfNqacpmcLwq79lWTDNNKcND5P0AhEenfjVRzoSmqDrz9Ba6qJq67bw1jGqVQyDrofg-5WKUUfTB1XJY2toaC2fk3X_7N3n-HXx86m9ku_oEPwvkndS1_CA</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>Gorard, D A</creator><general>Oxford Publishing Limited (England)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7T2</scope><scope>7U2</scope><scope>C1K</scope><scope>7TB</scope><scope>8FD</scope><scope>FR3</scope><scope>F28</scope></search><sort><creationdate>20061101</creationdate><title>Escalating polypharmacy</title><author>Gorard, D A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-177e611d358567cce42ff829e9c6a72951ff4ff270eeb80ba06f84e8722710833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Drug Interactions</topic><topic>Humans</topic><topic>Polypharmacy</topic><topic>Self Administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gorard, D A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><jtitle>QJM : An International Journal of Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gorard, D A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Escalating polypharmacy</atitle><jtitle>QJM : An International Journal of Medicine</jtitle><addtitle>QJM</addtitle><date>2006-11-01</date><risdate>2006</risdate><volume>99</volume><issue>11</issue><spage>797</spage><epage>800</epage><pages>797-800</pages><issn>1460-2725</issn><eissn>1460-2393</eissn><abstract>New drug treatments, new indications for older drug treatments, lower thresholds for treating risk factors in preventative medicine, and an ageing population acquiring multiple pathologies all contribute to the development of polypharmacy. Longitudinal studies document the rise in prescribed medications, particularly in the elderly. The potential dangers of adverse drug reactions and interactions, poor adherence and confusion associated with ever-increasing polypharmacy are likely to worsen. Strategies to reduce prescribing will obviously decrease the dangers of polypharmacy. These include more considered prescribing when contemplating additions to patients' already lengthy prescription lists, and external reviews of medicine lists by a doctor or pharmacist. Despite such strategies, polypharmacy seems inevitable and considerations must be given to simplifying patients' multiple drug administrations using single-daily-dose regimens, fixed-dose combination pills, calendar-blister packaging and pill organizers.</abstract><cop>England</cop><pub>Oxford Publishing Limited (England)</pub><pmid>17030528</pmid><doi>10.1093/qjmed/hcl109</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1460-2725 |
| ispartof | QJM : An International Journal of Medicine, 2006-11, Vol.99 (11), p.797-800 |
| issn | 1460-2725 1460-2393 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_29853096 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals |
| subjects | Aged Aged, 80 and over Drug Interactions Humans Polypharmacy Self Administration |
| title | Escalating polypharmacy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A40%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Escalating%20polypharmacy&rft.jtitle=QJM%20:%20An%20International%20Journal%20of%20Medicine&rft.au=Gorard,%20D%20A&rft.date=2006-11-01&rft.volume=99&rft.issue=11&rft.spage=797&rft.epage=800&rft.pages=797-800&rft.issn=1460-2725&rft.eissn=1460-2393&rft_id=info:doi/10.1093/qjmed/hcl109&rft_dat=%3Cproquest_cross%3E1155578231%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229475842&rft_id=info:pmid/17030528&rfr_iscdi=true |